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Small organic molecules, especially in the
pharmaceutical sciences, tend to crystallise in a plethora
of different crystal forms, either as pure compounds or
with the inclusion of solvent molecules. Due to their
changed physico-chemical characteristics, such as
melting point, compressibility, solubility and thus
bioavailability, and physical and chemical stability,
different crystal forms can pose a problem to the
manufacture of medicines.[1] It is thus crucial to
understand the crystallisation behaviour and
manufacturability of these compounds in order to avoid
problems in the life-time of the medicine and costly
recalls comparable to ritonavir[2] or rotigotine.[3]
Bioactive molecules and pharmaceuticals typically have
multiple functional groups, enabling them to interact with
receptors and thus show pharmacological action. In the
solid-state, the interactions through these functional
groups are the driving forces of molecular recognition.
By applying X-ray and neutron diffraction methods as
well as thermoanalysis, vapour sorption and
spectroscopic analysis in combination with computational
techniques, we are probing the strong and weak
interactions within the crystal forms and during the
crystallisation in order to understand and predict their
characteristics.  
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Crystal diffraction data of heart fatty acid binding
protein (H-FABP) in complex with oleic acid were
measured at room temperature with high resolution X-ray
and neutron protein crystallography (0.98 Å and 1.90 Å
resolution respectively). These data provided very
detailed information about the cluster of water molecules
and the bound oleic acid in the H-FABP large internal
cavity. The jointly refined X-ray/neutron structure of
H-FABP was complemented by a transferred multipolar
electron density distribution using the parameters of the
ELMAM2 library. The resulting electron density allowed
a precise determination of the electrostatic potential in the
fatty acid (FA) binding pocket. Bader’s quantum theory
of atoms in molecules was then used to study interactions
involving the internal water molecules, the FA and the
protein. This approach showed H-H contacts of the FA
with highly conserved hydrophobic residues known to
play a role in the stabilization of long chain FAs in the
binding cavity. The determination of water hydrogen
(deuterium) positions allowed the analysis of the
orientation and electrostatic properties of the water
molecules in the very ordered cluster. As a result, a
significant alignment of the water molecules permanent
dipoles with the protein electrostatic field was observed.
This can be related to the dielectric properties of
hydration layers around proteins, where the shielding of
electrostatic interactions depends directly on the
rotational degrees of freedom of the water molecules in
the interface. 
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